4
Changes in Ownership
NEKTAR THERAPEUTICS Filed Acc 0000950170-24-019043
President & CEO sold 20,033 shares at $0.68 ($13,622)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| ROBIN HOWARD W President & CEO | 2024-02-20 | Sale | −20,033 | $0.68 | $13,622 | 879,889 | D: show line 1 in the form |
| Open-market sales · 20,033 sh · avg $0.68 · $13,622 | |||||||
Loading xslF345X05/ownership.xml…